MERIT MEDICAL SYSTEMS INC (MMSI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 600M 1.2B 1.8B Q3 '21: 1.1B Q4 '21: 1.1B Q1 '22: 1.1B Q2 '22: 1.1B Q3 '22: 1.1B Q4 '22: 1.2B Q1 '23: 1.2B Q2 '23: 1.2B Q3 '23: 1.2B Q4 '23: 1.3B Q1 '24: 1.3B Q2 '24: 1.3B Q3 '24: 1.3B Q4 '24: 1.4B Q1 '25: 1.4B Q2 '25: 1.4B Q3 '25: 1.5B Q4 '25: 1.5B Q1 '26: 1.5B Q2 '26: 1.6B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 300M 600M 900M Q3 '21: 467.7M Q4 '21: 485.3M Q1 '22: 494.3M Q2 '22: 505.3M Q3 '22: 513.4M Q4 '22: 519.1M Q1 '23: 536.6M Q2 '23: 554.3M Q3 '23: 567.9M Q4 '23: 583.9M Q1 '24: 597.2M Q2 '24: 605.5M Q3 '24: 620.9M Q4 '24: 643.3M Q1 '25: 663.6M Q2 '25: 687M Q3 '25: 715.9M Q4 '25: 738.3M Q1 '26: 751M Q2 '26: 781.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

0 70M 140M 210M Q3 '21: 55M Q4 '21: 60.9M Q1 '22: 62M Q2 '22: 76.3M Q3 '22: 79M Q4 '22: 87.6M Q1 '23: 98.7M Q2 '23: 104.3M Q3 '23: 120.7M Q4 '23: 123.9M Q1 '24: 133.5M Q2 '24: 150.6M Q3 '24: 152.7M Q4 '24: 155.7M Q1 '25: 160.8M Q2 '25: 161.7M Q3 '25: 167.1M Q4 '25: 184.7M Q1 '26: 187.8M Q2 '26: 201.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

0 50M 100M 150M Q3 '21: 43.2M Q4 '21: 48.5M Q1 '22: 48M Q2 '22: 58.4M Q3 '22: 61.7M Q4 '22: 74.5M Q1 '23: 84.7M Q2 '23: 89.6M Q3 '23: 100.2M Q4 '23: 94.4M Q1 '24: 101.9M Q2 '24: 117.4M Q3 '24: 120M Q4 '24: 120.4M Q1 '25: 122.3M Q2 '25: 119.1M Q3 '25: 118.4M Q4 '25: 128.5M Q1 '26: 139.3M Q2 '26: 145.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 300M 600M 900M Q3 '21: 586.6M Q4 '21: 589.4M Q1 '22: 606.9M Q2 '22: 610.6M Q3 '22: 622.7M Q4 '22: 631.9M Q1 '23: 636.6M Q2 '23: 643.9M Q3 '23: 658.4M Q4 '23: 673.5M Q1 '24: 686.1M Q2 '24: 695.7M Q3 '24: 705M Q4 '24: 713.2M Q1 '25: 724.7M Q2 '25: 745.8M Q3 '25: 761.2M Q4 '25: 777.6M Q1 '26: 791.4M Q2 '26: 797.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

0 150M 300M 450M Q3 '21: 138.3M Q4 '21: 147.2M Q1 '22: 124M Q2 '22: 121.6M Q3 '22: 132.1M Q4 '22: 114.3M Q1 '23: 116.8M Q2 '23: 95.3M Q3 '23: 110.9M Q4 '23: 145.2M Q1 '24: 166.8M Q2 '24: 218M Q3 '24: 214.3M Q4 '24: 220.8M Q1 '25: 225.2M Q2 '25: 240M Q3 '25: 267.6M Q4 '25: 297.4M Q1 '26: 297.5M Q2 '26: 283.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

0 80M 160M 240M Q3 '21: 108.3M Q4 '21: 119.3M Q1 '22: 92.7M Q2 '22: 89.7M Q3 '22: 91.2M Q4 '22: 69.3M Q1 '23: 68.5M Q2 '23: 48.5M Q3 '23: 71.3M Q4 '23: 110.9M Q1 '24: 133.6M Q2 '24: 180M Q3 '24: 175.5M Q4 '24: 185.7M Q1 '25: 180.6M Q2 '25: 192.3M Q3 '25: 206.9M Q4 '25: 215.7M Q1 '26: 220.8M Q2 '26: 203.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q1 '20: 55.2M Q2 '20: 55.4M Q3 '20: 55.5M Q1 '21: 57M Q2 '21: 57.3M Q3 '21: 57.5M Q1 '22: 57.5M Q2 '22: 57.6M Q3 '22: 57.6M Q1 '23: 58.2M Q2 '23: 58.5M Q3 '23: 58.4M Q1 '24: 58.6M Q2 '24: 58.7M Q3 '24: 59.5M Q1 '25: 61.3M Q2 '25: 60.6M Q3 '25: 59.9M Q1 '26: 60M Q2 '26: 60M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.90 1.80 2.70 Q3 '21: 0.76 Q4 '21: 0.84 Q1 '22: 0.83 Q2 '22: 1.01 Q3 '22: 1.07 Q4 '22: 1.30 Q1 '23: 1.48 Q2 '23: 1.56 Q3 '23: 1.73 Q4 '23: 1.63 Q1 '24: 1.75 Q2 '24: 2.01 Q3 '24: 2.05 Q4 '24: 2.03 Q1 '25: 2.04 Q2 '25: 1.97 Q3 '25: 1.95 Q4 '25: 2.13 Q1 '26: 2.32 Q2 '26: 2.43 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.